Wednesday, August 17, 2011 5:57:38 PM
OK I'll grant that you have a fraction of an issue here and apologize if I misinterpreted your concern.
When a company has a secondary (the usual one time deal) There are two ways the broker can get compensated:
1) By commission: the broker immediately sells and puts on the market the shares it receives and gives the money to the company after deducting a commission.
2) by shares as a commission: the company immediately sells and puts on the market those shares that are not part of its commission and gives the money to the company.
Under this option the broker may be required to hold the shares received as commission for a period of time (to avoid flooding the market with shares. But not always.
What may be confusing ALL of us here is that the CSC agreement really appears to be a HYBRID of the two usual options:
Instead of a commission CSC receives a DISCOUNT in the price it pays KBLB for shares. THIS BLURS THE DISTINCTION BETWEEN A COMMISSION RECEIVED IN CASH AND ONE IN SHARES.
So you might have an argument for saying that CSC should have been obligated to hold an amount equivalent to its deduction/commission in shares for a period but certainly no argument IMHO for saying it should be required to hold ALL shares for a period. I'm not saying I agree with a contention that CSC should have been obligated to hold a fraction of the shares for a period but I grant that you could make an argument for it. However under the agreement CSC clearly is not obligated to do so. So you have to admit that, under the terms of the agreement KBLB is more similar to a loaner than to an investor but still, in actuality, a broker.
Even if your argument was considered valid (and I'm not at all sure that it is) your point would be limited to CSC not being required to hold a fraction of the shares (about 20%) for a period rather than being KBLB not being required to hold all of them. In that case you could say that KBLB didn't get the best deal. However, considering the marked benefits from the line of credit nature of the agreement which have clearly very markedly reduced dilution (to more than 80% LESS than the number of shares that would have been added to the market under a typical all-up-front deal) I think that the CSC agreement is still strongly overall positive for KBLB.
Could it have been even better? Maybe, but I'm quite satisfied with the way it is considering what the usual is and what the results of the usual would have been: more than 5 times as many shares put on the market.
I apologize for apparently originally misinterpreting the basis of your concern. But I continue to believe that you are looking at KBLB with a jaundiced eye. Perhaps both of us should try taking a few minutes pause to consider before responding to each others posts for awhile. I probably need to be more fair to you and IMHO you probably need to be more fair to KBLB. It is not reasonable to expect KBLB to come up with ideal solutions when none exists which IMHO is what some are apparently doing.
When a company has a secondary (the usual one time deal) There are two ways the broker can get compensated:
1) By commission: the broker immediately sells and puts on the market the shares it receives and gives the money to the company after deducting a commission.
2) by shares as a commission: the company immediately sells and puts on the market those shares that are not part of its commission and gives the money to the company.
Under this option the broker may be required to hold the shares received as commission for a period of time (to avoid flooding the market with shares. But not always.
What may be confusing ALL of us here is that the CSC agreement really appears to be a HYBRID of the two usual options:
Instead of a commission CSC receives a DISCOUNT in the price it pays KBLB for shares. THIS BLURS THE DISTINCTION BETWEEN A COMMISSION RECEIVED IN CASH AND ONE IN SHARES.
So you might have an argument for saying that CSC should have been obligated to hold an amount equivalent to its deduction/commission in shares for a period but certainly no argument IMHO for saying it should be required to hold ALL shares for a period. I'm not saying I agree with a contention that CSC should have been obligated to hold a fraction of the shares for a period but I grant that you could make an argument for it. However under the agreement CSC clearly is not obligated to do so. So you have to admit that, under the terms of the agreement KBLB is more similar to a loaner than to an investor but still, in actuality, a broker.
Even if your argument was considered valid (and I'm not at all sure that it is) your point would be limited to CSC not being required to hold a fraction of the shares (about 20%) for a period rather than being KBLB not being required to hold all of them. In that case you could say that KBLB didn't get the best deal. However, considering the marked benefits from the line of credit nature of the agreement which have clearly very markedly reduced dilution (to more than 80% LESS than the number of shares that would have been added to the market under a typical all-up-front deal) I think that the CSC agreement is still strongly overall positive for KBLB.
Could it have been even better? Maybe, but I'm quite satisfied with the way it is considering what the usual is and what the results of the usual would have been: more than 5 times as many shares put on the market.
I apologize for apparently originally misinterpreting the basis of your concern. But I continue to believe that you are looking at KBLB with a jaundiced eye. Perhaps both of us should try taking a few minutes pause to consider before responding to each others posts for awhile. I probably need to be more fair to you and IMHO you probably need to be more fair to KBLB. It is not reasonable to expect KBLB to come up with ideal solutions when none exists which IMHO is what some are apparently doing.
Recent KBLB News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/29/2026 04:15:07 AM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
- Advanced Materials Science 2026: How Spider Silk, Carbon Fiber & Aerogels are Powering Medicine, Defense & Space Tech Today • GlobeNewswire Inc. • 04/14/2026 01:20:00 PM
- From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle • GlobeNewswire Inc. • 04/13/2026 11:05:00 AM
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
